ACET: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Research and development	17M	23M	28M	23M	26M	26M
Selling, general and administrative	4M	5M	4M	7M	7M	7M
Operating expenses	22M	28M	32M	30M	33M	33M
Operating income	−22M	−28M	−32M	−30M	−33M	−33M
Interest expense	23,000	12,000	0	0	1,000	0
Pre-tax income	−20M	−27M	−31M	−28M	−30M	−30M
Income tax	0	0	0	0	0	0
Net income	−20M	−27M	−31M	−28M	−30M	−30M
Earnings per share	−1.88	−0.29	−0.34	−0.31	−0.34	−0.33
Earnings per share, diluted	−1.88	−0.29	−0.34	−0.31	−0.34	−0.33
Weighted average shares	11M	91M	91M	91M	91M	91M
Weighted average shares, diluted	11M	91M	91M	91M	91M	91M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	36M	39M	29M	35M	28M	56M	105M	224M
Short-term investments	—	—	—	—	—	—	97M	—
Current assets	140M	161M	106M	128M	154M	180M	206M	228M
Property, plant and equipment	15M	17M	18M	20M	21M	23M	24M	24M
Total assets	169M	192M	140M	163M	191M	220M	246M	269M
Current liabilities	18M	22M	19M	17M	16M	19M	19M	18M
Total liabilities	29M	33M	31M	30M	30M	34M	34M	34M
Equity	140M	159M	109M	133M	161M	187M	212M	235M
Shares outstanding	10M	10M	83M	83M	83M	5M	82M	82M
Shares issued	10M	10M	83M	83M	83M	5M	82M	82M

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	−21M	—	—	−25M	—	—
Depreciation and amortisation	1M	2M	2M	2M	2M	2M
Share-based compensation	1M	3M	3M	3M	7M	6M
Capital expenditure	37,000	—	—	1M	—	—
Investing cash flow	19M	—	—	−3M	—	—
Financing cash flow	−65,000	—	—	−104,000	—	—